Immunopathogenesis of 2009 pandemic influenza

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue SUPPL. 4, 2012, Pages 18-24

  Almansa, Raquel ^a,b,c   Bermejo Martín, Jesús F ^a,b,c   De Lejarazu Leonardo, Raúl Ortiz ^a,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b Instituto de Estudios de Ciencias de La Salud de Castilla y Leon   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adaptative; Antibody; Cross immunity; H1N1pdm; Hypercytokinemia; Immune dysfunction; Influenza; Innate; T cell; Viral escape

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; VASCULOTROPIN;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL DIFFERENTIATION; CYTOKINE RELEASE; CYTOKINE STORM; DISEASE SEVERITY; GENE EXPRESSION; HEMAGGLUTINATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; MORTALITY; NONHUMAN; OBESITY; RESPIRATORY FAILURE; SURVIVAL RATE; T LYMPHOCYTE; VIRUS EXCRETION; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

CYTOKINES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; SEVERITY OF ILLNESS INDEX;

EID: 84868116761     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(12)70100-3     Document Type: Article

References (95)

1. A. Nicoll, and D. Coulombier Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices Euro Surveill 14 2009 19279
2. Health Protection Agency; Health Protection Scotland; National Public Health Service for Wales; HPA Northern Ireland Swine influenza investigation teams Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009 Euro Surveill 14 2009 19232
3. A. Gilsdorf, G. Poggensee Working Group Pandemic Influenza A(H1N1)v Influenza A(H1N1)v in Germany: the first 10,000 cases Euro Surveill. 14 2009 19318
4. S.A. Webb, V. Pettila, I. Seppelt, R. Bellomo, M. Bailey, and D.J. Cooper Critical care services and 2009 H1N1 influenza in Australia and New Zealand N Engl J Med 361 2009 1925 1934
5. S. Jain, L. Kamimoto, A.M. Bramley, A.M. Schmitz, S.R. Benoit, and J. Louie Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 N Engl J Med 361 2009 1935 1944
6. A. Kumar, R. Zarychanski, R. Pinto, D.J. Cook, J. Marshall, and J. Lacroix Critically ill patients with 2009 influenza A(H1N1) infection in Canada Jama 302 2009 1872 1879
7. J. Rello, A. Rodríguez, P. Ibañez, L. Socias, J. Cebrian, A. Marques H1N1 SEMICYUC Working Group Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain Crit Care 13 2009 R148
8. L. Vaillant, G. La Ruche, A. Tarantola, P. Barboza epidemic intelligence team at InVS Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009 Euro Surveill 14 2009 19309
9. D. Viasus, J.R. Paño-Pardo, J. Pachón, A. Campins, F. López-Medrano, and A. Villoslada Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI). Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain Clin Microbiol Infect 17 2011 738 746
10. A.E. González-Vélez, C. Díaz-Agero-Perez, A. Robustillo-Rodela, A.M. Cornejo-Gutiérrez, M.J. Pita-López, and L. Oliva-Iñíguez Factores asociados a ingreso en unidad de cuidados intensivos en pacientes hospitalizados por Influenza pandémica A/H1N1 2009 Med Intensiva 35 2011 463 469
11. G.L. Ada, and P.D. Jones The immune response to influenza infection Curr Top Microbiol Immunol 128 1986 1 54
12. C.J. Sanders, P.C. Doherty, and P.G. Thomas Respiratory epithelial cells in innate immunity to influenza virus infection Cell Tissue Res 343 2011 13 21
13. M.J. Cameron, J.F. Bermejo-Martin, A. Danesh, M.P. Muller, and D.J. Kelvin Human immunopathogenesis of severe acute respiratory syndrome (SARS) Virus Res 133 2008 13 19 (Pubitemid 351374749)
14. C.M. Cameron, M.J. Cameron, J.F. Bermejo-Martin, L. Ran, L. Xu, and P.V. Turner Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets J Virol 82 2008 11308 11317
15. J.F. Bermejo-Martin, M.C. García-Arevalo, A. Alonso, R.O. De Lejarazu, M. Pino, and S. Resino Persistence of proinflammatory response after severe respiratory syncytial virus disease in children J Allergy Clin Immunol 119 2007 1547 1550 (Pubitemid 46855861)
16. M.J. Cameron, L. Ran, L. Xu, A. Danesh, J.F. Bermejo-Martin, and C.M. Cameron Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome J Virol 81 2007 8692 8706 (Pubitemid 47242843)
17. M.D. De Jong, C.P. Simmons, T.T. Thanh, V.M. Hien, G.J. Smith, and T.N. Chau Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia Nat Med 12 2006 1203 1207 (Pubitemid 44527358)
18. P. Osterlund, J. Pirhonen, N. Ikonen, E. Ronkko, M. Strengell, and S.M. Makela Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons J Virol 84 2010 1414 1422
19. H. Zeng, C. Pappas, J.M. Katz, and T.M. Tumpey The 2009 pandemic H1N1 and triplereassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells J Virol 85 2011 686 696
20. J.F. Bermejo-Martín, R. Ortiz de Lejarazu, T. Pumarola, J. Rello, R. Almansa, and P. Ramírez Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza Crit Care 13 2009 R201
21. K.K. To, I.F. Hung, I.W. Li, K.L. Lee, C.K. Koo, and W.W. Yan Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection Clin Infect Dis 50 2010 850 859
22. N. Hagau, A. Slavcovici, D.N. Gonganau, S. Oltean, D.S. Dirzu, and E.S. Brezoszki Clinical aspects and cytokine response in severe H1N1 influenza A virus infection Crit Care 14 2010 R203
23. V.A. Arankalle, K.S. Lole, R.P. Arya, A.S. Tripathy, A.Y. Ramdasi, and M.S. Chadha Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients PLoS One 2010 5 pii: e13099
24. I. Julkunen, T. Sareneva, J. Pirhonen, T. Ronni, K. Melen, and S. Matikainen Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression Cytokine Growth Factor Rev 12 2001 171 180 (Pubitemid 32588143)
25. R.M. Strieter, J.A. Belperio, and M.P. Keane Host innate defenses in the lung: the role of cytokines Curr Opin Infect Dis 16 2003 193 198 (Pubitemid 36677311)
26. K.J. Flynn, G.T. Belz, J.D. Altman, R. Ahmed, D.L. Woodland, and P.C. Doherty Virus-specific CD8+ T cells in primary and secondary influenza pneumonia Immunity 8 1998 683 691 (Pubitemid 28294515)
27. P. Fietta, and G. Delsante The effector T helper cell triade Riv Biol 102 2009 61 74
28. A. Nalbandian, J.C. Crispin, and G.C. Tsokos Interleukin-17 and systemic lupus erythematosus: current concepts Clin Exp Immunol 157 2009 209 215
29. T. Korn, M. Oukka, V. Kuchroo, and E. Bettelli Th17 cells: effector T cells with inflammatory properties Semin Immunol 19 2007 362 371 (Pubitemid 351274046)
30. J. Louten, K. Boniface, and R. De Waal Malefyt Development and function of TH17 cells in health and disease J Allergy Clin Immunol 123 2009 1004 1011
31. H.C. Toh, L. Sun, Y. Soe, Y. Wu, Y.P. Phoon, and W.K. Chia G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo Clin Immunol 132 2009 Jul 83 92
32. R. Almansa, L. Socias, P. Ramirez, I. Martin-Loeches, J. Vallés, and A. Loza Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza Crit Care 15 2011 448
33. E. Bautista, T. Chotpitayasunondh, Z. Gao, S.A. Harper, M. Shaw, and T.M. Uyeki Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection N Engl J Med 362 2010 1708 1719
34. S.G. Paquette, D. Banner, Z. Zhao, Y. Fang, S.S. Huang, and A.J. Leomicronn Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection PLoS One 7 2012 e38214
35. J. Zúñiga, M. Torres, J. Romo, D. Torres, L. Jiménez, and G. Ramírez Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City Autoimmunity 44 2011 562 570
36. J.F. Bermejo-Martín, I. Martín-Loeches, J. Rello, A. Antón, R. Almansa, and L. Xu Host adaptive immunity deficiency in severe pandemic influenza Crit Care 14 2010 R167
37. Y. Zhang, J. Li, Y. Zhan, L. Wu, X. Yu, and W. Zhang Analysis of serum cytokines in patients with severe acute respiratory syndrome Infect Immun 72 2004 Aug 4410 4415 (Pubitemid 38989297)
38. K.J. Huang, I.J. Su, M. Theron, Y.C. Wu, S.K. Lai, and C.C. Liu An interferon-gammarelated cytokine storm in SARS patients J Med Virol 75 2005 185 194 (Pubitemid 40053727)
39. D.P. Skoner, D.A. Gentile, A. Patel, and W.J. Doyle Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus J Infect Dis 180 1999 10 14 (Pubitemid 29293911)
40. D. Gentile, W. Doyle, T. Whiteside, P. Fireman, F.G. Hayden, and D. Skoner Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection Clin Diagn Lab Immunol 5 1998 604 608 (Pubitemid 29030752)
41. R.S. Fritz, F.G. Hayden, D.P. Calfee, L.M. Cass, A.W. Peng, and W.G. Alvord Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment J Infect Dis 180 1999 586 593 (Pubitemid 29411341)
42. G. Pavlisa, G. Pavlisa, V. Kusec, S.O. Kolonic, A.S. Markovic, and B. Jaksic Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD Eur Cytokine Netw 21 2010 92 98 Jun
43. M.M. Kilani, K.A. Mohammed, N. Nasreen, J.A. Hardwick, M.H. Kaplan, and R.S. Tepper Respiratory syncytial virus causes increased bronchial epithelial permeability Chest 126 2004 186 191 (Pubitemid 38943136)
44. N. Venteclef, and P. Delerive Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response J Biol Chem 282 2007 4393 4399 (Pubitemid 47100919)
45. K.K. McKinstry, T.M. Strutt, A. Buck, J.D. Curtis, J.P. Dibble, and G. Huston IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge J Immunol 182 2009 7353 7363
46. B.G. Hale, R.A. Albrecht, and A. Garcia-Sastre Innate immune evasion strategies of influenza viruses Future Microbiol 5 2010 23 41
47. M. Liang, D.C. Lye, M.I. Chen, A. Chow, P. Krishnan, and E. Seow New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases Singapore Med J 50 2009 581 583
48. L.M. Ling, A.L. Chow, D.C. Lye, A.S. Tan, P. Krishnan, and L. Cui Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection Clin Infect Dis 50 2010 963 969
49. N. Lee, P.K. Chan, C.K. Wong, K.T. Wong, K.W. Choi, and G.M. Joynt Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia Antivir Ther 16 2011 237 247
50. N. Lee, P.K. Chan, D.S. Hui, T.H. Rainer, E. Wong, and K.W. Choi Viral loads and duration of viral shedding in adult patients hospitalized with influenza J Infect Dis 200 2009 492 500
51. R. Almansa, A. Anton, P. Ramirez, I. Martin-Loeches, D. Banner, and T. Pumarola Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza BMC Infect Dis 11 2010 232
52. G. Chowell, S.M. Bertozzi, M.A. Colchero, H. Lopez-Gatell, C. Alpuche-Aranda, and M. Hernandez Severe respiratory disease concurrent with the circulation of H1N1 influenza N Engl J Med 361 2009 674 679
53. K. Hancock, V. Veguilla, X. Lu, W. Zhong, E.N. Butler, and H. Sun Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus N Engl J Med 361 2009 1945 1952
54. E. Miller, K. Hoschler, P. Hardelid, E. Stanford, N. Andrews, and M. Zambon Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study Lancet 375 2010 1100 1108
55. R. Booy, G. Khandaker, L.G. Heron, J. Yin, B. Doyle, and K.K. Tudo Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians Med J Aust 194 2011 19 23
56. S. Cherian, P. Shil, and A.C. Mishra Antigen-Antibody docking reveals the molecular basis for cross-reactivity of the 1918 and 2009 Influenza A/H1N1 pandemic viruses Bioinformation 6 2011 35 38
57. W. Zhang, J. Qi, Y. Shi, Q. Li, F. Gao, and Y. Sun Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus Protein Cell 1 2010 459 467
58. O. Miotto, A.T. Heiny, R. Albrecht, A. García-Sastre, T.W. Tan, and J.T. August Completeproteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains PLoS One 5 2010 e9025
59. A.C. Monsalvo, J.P. Batalle, M.F. Lopez, J.C. Krause, J. Klemenc, and J.Z. Hernandez Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes Nat Med 17 2010 195 199
60. X. Ge, V. Tan, P.L. Bollyky, N.E. Standifer, E.A. James, and W.W. Kwok Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swineorigin influenza A virus J Virol 84 2010 Apr 3312 3319
61. W. Tu, H. Mao, J. Zheng, Y. Liu, S.S. Chiu, and G. Qin Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus J Virol 84 2010 6527 6535
62. T.P. Rygiel, E.S. Rijkers, T. De Ruiter, E.H. Stolte, M. Van der Valk, and G.F. Rimmelzwaan Lack of CD200 enhances pathological T cell responses during influenza infection J Immunol 183 2009 1990 1996
63. C.V. Ramana, G.S. Cheng, A. Kumar, H.J. Kwon, and R.I. Enelow Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury Mol Immunol 47 2009 623 631
64. R. Le Goffic, V. Balloy, M. Lagranderie, L. Alexopoulou, N. Escriou, and R. Flavell Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virusinduced acute pneumonia PLoS Pathog 2 2006 Jun e53
65. T. Mauad, L.A. Hajjar, G.D. Callegari, L.F. Da Silva, D. Schout, and F.R. Galas Lung pathology in fatal novel human influenza A (H1N1) infection Am J Respir Crit Care Med 181 2010 72 79
66. C. Agrati, C. Gioia, E. Lalle, E. Cimini, C. Castilletti, and O. Armignacco Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course J Infect Dis 202 2010 681 689
67. E.J. Giamarellos-Bourboulis, M. Raftogiannis, A. Antonopoulou, F. Baziaka, P. Koutoukas, and A. Savva Effect of the novel influenza A (H1N1) virus in the human immune system PLoS One 4 2009 e8393
68. D.J. Jamieson, M.A. Honein, S.A. Rasmussen, J.L. Williams, D.L. Swerdlow, and M.S. Biggerstaff H1N1 2009 influenza virus infection during pregnancy in the USA Lancet 374 2009 451 458
69. J.K. Louie, M. Acosta, D.J. Jamieson, and M.A. Honein Severe 2009 H1N1 influenza in pregnant and postpartum women in California N Engl J Med 362 2010 27 35
70. J.K. Louie, D.A. Wadford, A. Norman, and D.J. Jamieson 2009 pandemic influenza A (H1N1) and vaccine failure in pregnancy Obstet Gynecol 117 2 Pt 2 2011 470 472
71. O.W. Morgan, A. Bramley, A. Fowlkes, D.S. Freedman, T.H. Taylor, and P. Gargiullo Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease PLoS One 5 2010 e9694
72. J.K. Louie, M. Acosta, M.C. Samuel, R. Schechter, D.J. Vugia, and K. Harriman A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1) Clin Infect Dis 52 2011 301 312
73. R. Almansa, M. Sanchez-Garcia, A. Herrero, S. Calzada, V. Roig, and J. Barbado Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease J Interferon Cytokine Res 31 2011 409 413
74. A.G. Smith, P.A. Sheridan, R.J. Tseng, J.F. Sheridan, and M.A. Beck Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in dietinduced obese mice infected with influenza virus Immunology 126 2009 268 279
75. C.M. Bauer, C.C. Zavitz, F.M. Botelho, K.N. Lambert, E.G. Brown, and K.L. Mossman Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection PLoS One 5 2011 e13251
76. H. Nave, G. Beutel, and J.T. Kielstein Obesity-related immunodeficiency in patients with pandemic influenza H1N1 Lancet Infect Dis 11 2011 14 15
77. J.D. Easterbrook, R.L. Dunfee, L.M. Schwartzman, B.W. Jagger, A. Sandouk, and J.C. Kash Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus Influenza Other Respi Viruses 5 2011 418 425
78. D.J. Jamieson, J.E. Ellis, D.B. Jernigan, and T.A. Treadwell Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists Am J Obstet Gynecol 194 2006 1546 1555 (Pubitemid 43766932)
79. N. Uchide, K. Ohyama, T. Bessho, and H. Toyoda Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection Med Sci Monit 11 2005 RA7 RA16
80. T.A. Kraus, R.S. Sperling, S.M. Engel, Y. Lo, L. Kellerman, and T. Singh Peripheral blood cytokine profiling during pregnancy and post-partum periods Am J Reprod Immunol 64 2010 411 426
81. K.H. Chan, A.J. Zhang, K.K. To, C.C. Chan, V.K. Poon, and K. Guo Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice PLoS One 5 2010 e13757
82. G. Marcelin, J.R. Aldridge, S. Duan, H.E. Ghoneim, J. Rehg, and H. Marjuki Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice J Virol 85 2011 11208 11219
83. J. Juno, K.R. Fowke, and Y. Keynan Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses Clin Dev Immunol 2012 2011 797180
84. I. Martin-Loeches, T. Lisboa, A. Rhodes, R.P. Moreno, E. Silva, and C. Sprung Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection Intensive Care Med 37 2011 272 283
85. S.H. Kim, S.B. Hong, S.C. Yun, W.I. Choi, J.J. Ahn, and Y.J. Lee Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores Am J Respir Crit Care Med 183 2011 1207 1214
86. C. Brun-Buisson, J.C. Richard, A. Mercat, A.C. Thiebaut, and L. Brochard Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome Am J Respir Crit Care Med 183 2011 1200 1206
87. I.M. Adcock, P.C. Chou, A. Durham, and P. Ford Overcoming steroid unresponsiveness in airways disease Biochem Soc Trans 37 Pt 4 2009 824 829
88. I.M. Adcock, and P.J. Barnes Molecular mechanisms of corticosteroid resistance Chest 134 2008 Aug 394 401
89. J.Y. Min, and Y.J. Jang Macrolide therapy in respiratory viral infections Mediators Inflamm 2012 649570
90. J.F. Bermejo-Martin, D.J. Kelvin, J.M. Eiros, J. Castrodeza, and R. Ortiz de Lejarazu Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains J Infect Dev Ctries 3 2009 159 161
91. T. Sawabuchi, S. Suzuki, K. Iwase, C. Ito, D. Mizuno, and H. Togari Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza Respirology 14 2009 Nov 1173 1179
92. I.F. Hung, K.K. To, C.K. Lee, K.L. Lee, K. Chan, and W.W. Yan Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection Clin Infect Dis 52 2011 447 456
93. S. Takeda, R. Munakata, S. Abe, S. Mii, M. Suzuki, and T. Kashiwada Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion Intensive Care Med 36 2010 906 907
94. L.M. Alleva, A.C. Budd, and I.A. Clark Systemic release of high mobility group box 1 protein during severe murine influenza J Immunol 181 2008 1454 1459
95. D.S. Fedson Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 8 2008 571 576